Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-704-5
CAS number: 98-82-8
For acute oral toxicity an LD50 of 2260 mg/kg bw is available. Data on inhalation toxicity revealed an LC50 >17.6 mg/L (=g/m3). And for dermal toxicity an LD50 >3160 mg/L was derived.
Data on acute toxicity are presented in Section 188.8.131.52.1 of the
EU RAR (2001; Section 184.108.40.206, page 57ff).
For the acute toxicity of cumene no guideline studies performed
under GLP are available. However, the data presented in a weight of
evidence approach are sufficient for the assessment and for
classification and labelling purposes.
ACUTE ORAL TOXICITY
For acute oral toxicity LD50 values between 1400 and 4000 mg/kg bw
have been reported in rats. Symptoms of toxicity included central
nervous depression. Post mortem examination showed haemorrhagic lungs,
liver discoloration and acute gastrointestinal inflammation. As most
relevant studies for this endpoint a LD50 of 2260 mg/kg bw obtained in
rats by Ciba Geigy (1985; see robust study summaries in IUCLID section
7.2.1) and an LD50 of 2700 mg/kg bw obtained in rats by Monsanto (1978,
see robust study summaries in IUCLID section 7.2.1) have been selected.
In the EU RAR the results of five other studies with rats are
reported, which support the findings listed above.
Based on the viscosity, the substance is classified for aspiration.
ACUTE INHALATION TOXICITY
Due to the volatility of cumene, the inhalation route may be the
most important for assessment. After a 6 h exposure no death occurred at
a concentration of 17.6 mg/L (Monsanto Corporation 1978, see robust
study summaries in IUCLID section 7.2.2), but 4 of 6 deaths were
observed after a 4 h exposure to 39.2 mg/L (Smyth et al. 1951, see
robust study summaries in IUCLID section 7.2.2). For mice a LC50 of 10
mg/L has been obtained after nose only exposure for 7 h (Werner et al.
1944, see robust study summaries in IUCLID section 7.2.2). The principal
causes of death in acutely exposed animals were respiratory paralysis,
pulmonary oedema and haemorrhaging associated with further haemorrhage
in the thymus, bladder and adrenals.
Therefore, a LC50 of >17.6 mg/L can be derived from the data
available. This value indicates a low acute toxicity in animals.
Other studies are available in the EU RAR with rats and mice,
which support the findings listed above. Results in mice leads to the
conclusion that the neurobehavioral effects are comparable to those
observed with phenobarbital.
ACUTE DERMAL TOXICITY
After dermal exposure of 3160 mg/kg bw no deaths were observed in
rabbits (Monsanto, 1978, see robust study summaries in IUCLID section
7.2.3). Therefore, an LD50 of >3160 mg/kg bw can be derived. Other
investigations revealed an LD50 10600 mg/kg bw (Smyth et al. 1951, see
robust study summaries in IUCLID section 7.2.3), while Ciba Geigy (1985,
see robust study summaries in IUCLID section 7.2.3) reported an LD0 of
10000 mg/kg bw. Weight loss, increasing weakness, collapse and death
were observed. Gross autopsy showed haemorrhagic areas of the lungs,
liver discoloration, darkened kidneys and spleen and gastrointestinal
No further studies were listed in the EU RAR.
Based on the information from acute toxicity tests, there is no need to
classify cumene as toxic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again